| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |